AI 채팅
Loading data for ELAB — first visit, this takes a few seconds.

PMGC Holdings Inc.

ELAB · NasdaqCM · USD

4.82 +0.20 (4.33%)

종가 기준: Sep 16, 2026, 8:00 PM

거래량
35.5K

PMGC Holdings Inc.(ELAB) 주가, 분석 및 데이터

내재가치

내재 가치 로딩 중…

애널리스트 전망

주가 전망 →

애널리스트 전망 없음

12개월 목표가 · 애널리스트 n/a명

애널리스트 컨센서스: n/a

간격:1D
캔들과 신호 불러오는 중…

재무 실적

재무 정보 보기 →

불러오는 중...

최근 실적

발표치예상 대비전년 대비
매출n/an/a
EPSn/an/a

다음 실적 발표

실적 상세 보기 →

지표

매수호가
4.02
순이익 (ttm)
-13.6M
-0.30
-1870.17
n/a
n/a
P/B (ttm)
0.18
P/S (ttm)
1.50
실적 발표일
n/a
매도호가
5.55
거래량
35,467
평균 거래량 (20일)
222,656
시가
4.64
전일 종가
4.62
일중 범위
4.55 - 4.90
52주 범위
4.40 - 2671.20
배당
n/a
배당락일
n/a

PMGC Holdings Inc. 소개

기업 정보 보기 →
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operating investment firms; providing packaging solutions to industrial and consumer markets; and design and production of high-tolerance components for industrial and technological applications. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California. Biotechnology · Healthcare

PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operating investment firms; providing packaging solutions to industrial and consumer markets; and design and production of high-tolerance components for industrial and technological applications. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.

섹터 Healthcare
IPO 일자 Nov 21, 2023
직원 수 32
상장 거래소 NasdaqCM
티커 ELAB